ask="3.100"
ask_size="50000"
average_daily_volume="3650070"
bid="3.080"
bid_size="1000"
book_value="-1.752"
change="+0.080"
change_from_200_day_moving_average="-1.639"
change_from_50_day_moving_average="-0.070"
change_from_52_week_high="-5.960"
change_From_52_week_low="0.225"
change_in_percent="+2.689%"
close="3.055"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.372"
ebitda="-120.56M"
eps_estimate_current_year="-1.160"
eps_estimate_next_quarter="-0.190"
eps_estimate_next_year="-0.580"
ex_dividend_date="N/A"
float_shares="113594000"
high="3.100"
high_52_weeks="9.015"
last_trade_date="3/2/2017"
last_trade_price="3.055"
last_trade_size="69870"
last_trade_time="4:00pm"
low="2.950"
low_52_weeks="2.830"
market_capitalization="395.97M"
moving_average_200_day="4.694"
moving_average_50_day="3.125"
name="Merrimack Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="9.000"
open="2.950"
pe_ratio="N/A"
peg_ratio="-1.180"
percent_change_from_200_day_moving_average="-34.920%"
percent_change_from_50_day_moving_average="-2.231%"
percent_change_from_52_week_high="-66.112%"
percent_change_from_52_week_low="+7.951%"
previous_close="2.975"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="3.692"
revenue="104.45M"
shares_outstanding="129615000"
short_ratio="4.680"
stock_exchange="NGM"
symbol="MACK"
volume="2260927"
weeks_range_52="2.830 - 9.015"
